Ovarian cancer is often called a "silent killer" because it typically presents with vague symptoms and lacks a reliable universal screening test. The CA-125 blood test is frequently mentioned in discussions about ovarian cancer detection, but understanding its capabilities and limitations is essential to using it appropriately.